Next Science Health Care
Biotech Healthcare New Zealand North America Pharmaceuticals

$0.580 (0%)

High $0.59	Low $0.57	Trades 36	Turnover $59,341	Volume 102,948
30 June 2023 at 3:56pm

Please note that we source our information from many sources. The below may not be accurate, or up to date. Please bear with us whilst we fine tune our data collection. In the meantime, we do not recommend relying on the below. It is merely a guide!

Stock Information

Code NXS	Name Next Science Ltd	Country AU	Currency AUD
GIC Sector Health Care	GIC Group Pharmaceuticals, Biotechnology & Life Sciences	GIC Industry Pharmaceuticals	GIC Sub Industry Pharmaceuticals
Sector Healthcare	IPO Date N/A	Fiscal Year December	Type Common Stock
Shares Outstanding 292,625,365	Shares Floated 139,249,411	Held by Insiders 51.909%	Held by Institutions 8.027%

Directors & Officers

Name & Education	Position
Dr. Matthew Franco Myntti	Founder & CTO
Mr. Jon Swanson	Chief Strategy Officer
Daniel Canon	Vice President of Operations
Francoise Dixon	Head of Investor Relations
Mr. Robert Bell	Senior Vice President of North American Sales
Ms. Gillian Maria Nairn AGIA, B.A., L.L.B., L.L.M., MAICD	Company Secretary

NXS Historic Dividends

Date	Amount
We found no dividends on record for NXS.

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.15	322,774	0.00 (0.00%)
12-Sep	$0.15	16,656	0.00 (0.00%)
11-Sep	$0.15	21,171	+0.00 (1.72%)
05-Sep	$0.15	30,368	0.00 (0.00%)
04-Sep	$0.15	715,906	0.00 (0.00%)
03-Sep	$0.15	206,354	0.00 (0.00%)
29-Aug	$0.15	54,648	0.00 (0.00%)
28-Aug	$0.15	31,929	0.00 (1.69%)
22-Aug	$0.15	825,106	+0.00 (1.72%)
21-Aug	$0.15	171,743	0.00 (0.00%)
15-Aug	$0.15	1,595	0.00 (0.00%)
14-Aug	$0.15	161,432	+0.00 (3.57%)
07-Aug	$0.14	230,003	0.00 (0.00%)
31-Jul	$0.14	461,648	0.00 (1.75%)
30-Jul	$0.14	1,557,393	+0.00 (1.79%)
4 up, 2 down, and 9 flat days

Market Cap (19-Sep) $42,430,680	EBITDA -	PE 128.21	Book Value $0.00
Dividend per Share $0.00	Dividend Yield 0%	EPS $-0.05	Profit Margin N/A
Operating Margin -41.23%	ROA 50.99%	ROE 289.7%	Revenue (FY) $22,068,816
Revenue per Share $0.08	Gross Profit (FY) $18,202,312	Q' YOY Revenue Growth 6.7%	Q' YOY Earnings Growth -

Next Science Health Care
Biotech Healthcare New Zealand North America Pharmaceuticals

Stock Information

Technicals

Financial Snapshot (June 2025)

Directors & Officers

NXS Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Next Science Health Care Biotech Healthcare New Zealand North America Pharmaceuticals

Stock Information

Technicals

Financial Snapshot (June 2025)

Directors & Officers

NXS Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Next Science Health Care
Biotech Healthcare New Zealand North America Pharmaceuticals